Market will ascribe value long before we get “the tick”, imo.
Once the weak hands have been shaken out we’ll be ready for the next run. Its setting up nicely.
BMS Lag3 Relatlimab approval early 2022 will be next big inflection point, imo. Astute investors would want to be on board before then.
Ann: Immutep Global Webcast Slides to Discuss Clinical Results, page-12
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.3¢ |
Change
0.003(0.86%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.5¢ | 29.0¢ | $82.67K | 282.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 34 | 352367 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 175836 | 23 |
View Market Depth
| Last trade - 11.46am 11/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |